A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer (Q61624856)
Jump to navigation
Jump to search
scientific article published on 12 June 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer |
scientific article published on 12 June 2007 |
Statements
A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer (English)
Janell Seeger
Norman Wolmark
Sheri K Dennison
Samuel A Jacobs
John W Wilson
Terrence P Cescon
Jane M Raymond
Charles E Geyer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference